MIM1;4-[[[2-(Cyclohexylimino)-4-methyl-3(2H)-thiazolyl]imino]methyl]-1,2,3-benzenetriol;1,2,3-Benzenetriol, 4-[[[2-(cyclohexyliMino)-4-;MIM 1;MIM-1;CS-1192;Inhibitor of Mcl-1;1,2,3-Benzenetriol, 4-[[[2-(cyclohexylimino)-4-methyl-3(2H)-thiazolyl]imino]methyl]-;inhibit,Bcl-2 Family,Inhibitor of Mcl1,Inhibitor,MIM-1,MIM1,MIM 1,Inhibitor of Mcl 1
MIM-1 is an inhibitor of myeloid cell leukemia 1 (Mcl-1), selectively targeting the BH3 binding groove of Mcl-1 and exhibiting Bak-dependent apoptotic activity; it is used to induce apoptosis in cancer cells, with demonstrated efficacy in HA and T98G cell lines (IC50 values of 16.10 µM and 80.20 µM, respectively).